[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565899":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":42,"centralContacts":47,"locations":52,"responsibleParty":70,"collaborators":37,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":37,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":37,"enrollmentInfo":81,"targetDuration":37,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":55,"whyStopped":37,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8,13,19],{"label":9,"type":6,"description":10,"interventionNames":11},"Controlled group-Blood glucose meters (BGM) group","The participants will receive structured questionnaires at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.\n\nParticipants are required to use blood glucose meters (BGM) at \"24-32 weeks of pregnancy\" and \"33 weeks to before delivery\". After 7-14 days of glucose monitoring at \"24-32 weeks of pregnancy\", glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at \"33 weeks to before delivery \", another glucose monitor reports will be given to the participants.",[12],"Other: Blood glucose meters (BGM)",{"label":14,"type":15,"description":16,"interventionNames":17},"Experimental group1-Continuous glucose monitoring (CGM) group","EXPERIMENTAL","The participants will receive structured questionnaires at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.\n\nParticipants will receive a set of continuous glucose monitor (CGM) respectively at \"24-32 weeks of pregnancy (first set)\" and \"33 weeks of pregnancy to before delivery (second set)\". After 7-14 days of glucose monitoring at \"24-32 weeks of pregnancy\", glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at \"33 weeks to before delivery \", another glucose monitor reports will be given to the participants.",[18],"Device: Continuous glucose monitor",{"label":20,"type":15,"description":21,"interventionNames":22},"Experimental group2-Continuous glucose monitoring (CGM) with nursing care group","The participants will receive structured questionnaires at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum, respectively.\n\nParticipants will receive a set of continuous glucose monitor (CGM) respectively at \"24-32 weeks of pregnancy (first set)\" and \"33 weeks of pregnancy to before delivery (second set)\". After 7-14 days of glucose monitoring at \"24-32 weeks of pregnancy\", glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at \"33 weeks to before delivery \", another glucose monitor reports will be given to the participants.\n\nParticipants will receive nursing care for gestational diabetes at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum.",[18,23],"Behavioral: Perinatal nursing care for gestational diabetes",[25,32,38],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DEVICE","Continuous glucose monitor","Participants will receive a set of continuous glucose monitor (CGM) at 24-32 weeks of pregnancy (first set); and 33 weeks of pregnancy to before delivery (second set) respectively.\n\nCGM wearing instruction will be provided before the first wearing at 24-32 weeks of pregnancy. After completing the first wearing (approximately 7-14 days after starting to wear), the investigators will provide glucose monitor reports. The second CGM was worn from the 33rd week of pregnancy to before delivery, and another glucose monitor reports was given approximately 7-14 days after starting to wear.",[14,20],[31],"Abbott FreeStyle Libre 2 (CGM)",{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":37},"BEHAVIORAL","Perinatal nursing care for gestational diabetes","Individual nursing care and consultation for women with gestational diabetes mellitus, including glucose monitor suggestions, dietary suggestions, emotional support, breastfeeding support at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum.",[20],null,{"type":6,"name":39,"description":40,"armGroupLabels":41,"otherNames":37},"Blood glucose meters (BGM)","Participants are required to use blood glucose meters (BGM) at 24-32 weeks of pregnancy and 33 weeks to before delivery. After 7-14 days of glucose monitoring at 24-32 weeks of pregnancy, glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at 33 weeks to before delivery, another glucose monitor reports will be given to the participants.",[9],[43],{"name":44,"affiliation":45,"role":46},"HUNG-HUI CHEN, PhD","National Taiwan University Hostiptal","PRINCIPAL_INVESTIGATOR",[48],{"name":44,"role":49,"phone":50,"phoneExt":37,"email":51},"CONTACT","886-2-2394-7109","hunghuichen@ntu.edu.tw",[53],{"facility":54,"status":55,"city":56,"state":37,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital","RECRUITING","Hsinchu","302058","Taiwan","TW",{"type":61,"coordinates":62},"Point",[63,64],120.96861,24.80361,{"lat":64,"lon":63},[67],{"name":68,"role":49,"phone":69,"phoneExt":37,"email":51},"HUNG-HUI CHEN","+886-2-23947109",{"type":71,"investigatorFullName":37,"investigatorTitle":37,"investigatorAffiliation":37,"oldNameTitle":37,"oldOrganization":37},"SPONSOR","100565899","the-project-for-managing-cardiometabolic-risk-in-women-diagnosed-with-gestational-diabetes-mellitus-100565899",false,"NCT06648174","The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus","The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus: The Development and Application of \"a Lifestyle Intervention Based on Health Belief Model Supported by Mobile Health\"","Inclusion Criteria:\n\n1. Aged 18 years or above\n2. Pregnant women diagnosed with gestational diabetes mellitus\n3. Willing to participate in the study\n\nExclusion Criteria:\n\n1. Diagnosed with diabetes mellitus before pregnancy\n2. Allergic to materials such as tapes (e.g., redness, swelling, itching, pain, blisters, or rashes caused by breathable tapes or patches)\n3. Abnormal coagulation function","FEMALE","18 Years",{"count":82,"type":83},120,"ESTIMATED","INTERVENTIONAL",[86],"NA","This study aims to examine the effects of a lifestyle intervention based on a health belief model (HBM) supported by mobile health (mHealth) and the impact of continuous glucose monitoring (CGM) on maternal glycemic parameters, cardiometabolic risk, health behavior and infant's outcomes among women diagnosed with gestational diabetes mellitus (GDM).",[89,90],"Gestational Diabetes Mellitus","Continuous Glucose Monitoring",[89,90,92],"Health Interventions","2026-01-16",{"date":95,"type":96},"2026-01-20","ACTUAL",{"date":98,"type":96},"2024-11-11",{"date":100,"type":83},"2027-12-31",{"name":5,"class":6},1]